Developer docs
API playgroundTry for free, no card

Search company profiles

Gencove

Full company profile

uuid0000er6

Namestring
Gencove
Legal namestring
Gencove, Inc.
Websiteurl
gencove.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Gencove is a New York-based genomics technology company founded in 2015 that commercializes low-pass whole genome sequencing (lpWGS) — a method that reads the entire genome at approximately 0.5x coverage and uses a proprietary imputation pipeline, calibrated against large reference panels and tuned for accuracy across diverse ancestries, to infer millions of additional variants at >99% concordance with microarray genotyping for common variants. The company operates a dual-track business: a direct-to-consumer product (Gencove Consumer, launched March 2026, $69 per kit) delivering PRS-based health risk reports across nine traits, ancestry analysis, and raw data download; and an enterprise platform (Gencove Enterprise / Base / Explorer) serving pharmaceutical companies, biobanks, academic institutions, and agricultural genomics customers with population-scale sequencing workflows, a JupyterLab-based analysis cloud, a Python CLI/SDK, and a REST API with multi-region deployment.

The enterprise platform generates revenue through subscription/recurring platform services and project-based sequencing contracts with named customers including GSK, Boehringer Ingelheim, Stanford University, the University of Oxford, the USDA, Syngenta, Neogen, BGI, Element Biosciences, Ultima Genomics, Gene by Gene, and the Weizmann Institute. The consumer channel operates as a one-time e-commerce transaction priced at $69 per kit, with US-only shipping as of the disclosure date and international expansion publicly signaled. The company has raised approximately $16.15M across five funding rounds through 2021 (latest: $10M Series A led by Lewis & Clark AgriFood), holds 11–50 employees per the disclosed band, and is led by CEO Joe Pickrell and CTO/Co-founder Tomaz Berisa. Technical differentiators include imputation optimized for diverse ancestries, raw data ownership for customers (enabling reanalysis as science evolves), CLIA-certified laboratory processing, and EU-U.S./UK/Swiss Data Privacy Framework certifications supporting international data handling.

Short descriptiontext

Gencove is a New York-based genomics technology company offering low-pass whole genome sequencing with proprietary imputation to pharmaceutical, academic, agricultural, and consumer customers via an enterprise platform and a $69 DTC test kit.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLong Island City, United States
HQ citystring
Long Island City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
low-pass whole genome sequencing, polygenic risk scoring, consumer DNA testing, genomic imputation platform, enterprise genomics analytics
Industry6 codes
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYAFAEAJAC
Genomic Testing & Genetic Evaluation Services
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAANAL
Population Genomics & Preventive Precision Health Programs
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Genomic Sequencing & Analytics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Consumer DNA Testing Kits
TypeOne Time License
Description

Direct-to-consumer sales of at-home DNA collection kits at $69 per kit. Includes buccal swab collection, low-pass whole genome sequencing, polygenic risk score reports across 7+ health traits, ancestry analysis, and raw data download.

gencove.com:443
2Enterprise Genomic Platform
TypeSubscription Recurring
Description

B2B platform services for research institutions, biobanks, and pharmaceutical companies including assay development, sequencing, and data analytics & management solutions for population-scale genomics research.

enterprise.gencove.com
3Technology Partnership - Twist Bioscience
TypeLicensing Royalties
Description

Collaboration with Twist Bioscience for the FlexPrep Ultra-High Throughput Library Preparation Kit for agrigenomics and population genomics applications.

biospace.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Pricing details1 tier
1$69 consumer DNA test kit
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Includes at-home collection kit, sequencing-powered analysis, predisposition insights across 8 health traits (including ancestry), and raw data download. Shipping costs are added at checkout.

gencove.com:443
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 4 records shown
1Gencove Enterprise Platform
Description

Low-pass sequencing and imputation workflows for research institutions, biobanks, and pharmaceutical companies

enterprise.gencove.com
+3 more records
Core offering1 text field

Gencove sells low-pass whole genome sequencing (lpWGS) and imputation-based genomic analysis through two distinct channels: a direct-to-consumer $69 at-home DNA testing kit with Polygenic Risk Score reports across 8+ health traits and ancestry analysis, and an enterprise cloud platform (Gencove Base + Explorer) providing population-scale genomic sequencing, imputation, project/sample management, and analytical shortcuts for research institutions, biobanks, pharmaceutical companies, and agrigenomics customers. Both channels share the same proprietary lpWGS and imputation technology stack.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • >99% concordance with microarray genotyping for common variants (minor allele frequency >5%)
Product overview1 text field

Gencove operates as a genomics technology company offering a dual-track product portfolio. For consumers (Gencove Consumer), it provides at-home DNA testing using low-pass whole genome sequencing (lpWGS), delivering PRS-based health risk reports, ancestry analysis, and raw genomic data downloads for $69. For research and enterprise customers (Gencove Enterprise/Base), it provides a cloud-based sequencing analytics platform comprising Gencove Base (project/sample management via web dashboard, REST API, and CLI), Gencove Explorer (JupyterLab-based analysis cloud with shortcut library for VCF management, relatedness, and IGV), and the Gencove CLI (Python SDK). Both tracks share the same core lpWGS technology and imputation pipeline, with the consumer product packaging enterprise-grade genomic infrastructure into an accessible consumer offering.

Product and service2 records
1Gencove Consumer DNA Test Kit
CategoryConsumer Genomics / Direct-to-Consumer Genetic Testing
2Gencove Enterprise Platform
CategoryEnterprise Genomics / Population-Scale Sequencing
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-10-30
Description

Twist Bioscience launched the FlexPrep Ultra-High Throughput Library Preparation Kit designed for high-volume applications in agrigenomics and population genomics, collaborating with Gencove to enhance genomic analysis solutions. The kit offers significant cost and time savings by automating normalization and multiplexing processes, allowing up to 1,152 samples per run. The collaboration aims to accelerate adoption of next-generation sequencing (NGS) in large-scale genomic research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Element Biosciences is a sequencing instrument manufacturer whose AVITI system is positioned as a lower-cost alternative to Illumina. It is listed as a Gencove trusted partner and represents adjacent sequencing infrastructure that competes with and complements Gencove's platform.

TypeDirect peer
Description

23andMe is the largest direct-to-consumer genetic testing company, offering saliva-based DNA tests for ancestry and health traits. It is the most direct competitor to Gencove's $69 consumer kit, though 23andMe uses microarray genotyping rather than low-pass whole genome sequencing.

TypeBroad incumbent
Description

Ultima Genomics is a sequencing instrument company developing high-throughput, low-cost NGS platforms. Gencove is listed as a trusted partner with Ultima integration (October 2025), making Ultima both an infrastructure partner and adjacent player in low-cost sequencing.

TypeOthers
Description

Twist Bioscience is a synthetic biology and DNA synthesis company that partnered with Gencove on the FlexPrep Ultra-High Throughput Library Preparation Kit (October 2024). It is a key ecosystem partner enabling Gencove's agrigenomics throughput rather than a direct competitor.

TypeEmerging player
Description

Helix operates a sequencing-as-a-service platform serving health systems, population health programs, and consumer applications. It competes with Gencove Enterprise in population-scale genomic analysis and offers its own consumer-facing products through partners.

TypeEmerging player
Description

Color Health provides genetic testing with a focus on clinical-grade health screening, population health programs, and enterprise health benefits. It overlaps with Gencove in genetic testing and population genomics but emphasizes clinical utility rather than raw data ownership or sequencing methodology.

7BGI
TypeBroad incumbent
Description

BGI is a global genomics organization with sequencing services, instrument manufacturing (MGI), and large-scale population genomics programs. It is a listed Gencove partner and broader incumbent in genomics services with significantly greater scale and geographic reach.

8Ancestry (AncestryDNA)
TypeDirect peer
Description

AncestryDNA is a major consumer genetic testing service focused primarily on ancestry and family history, with microarray-based genotyping. It competes directly with Gencove Consumer in the DTC market and has a substantially larger customer base and brand recognition.

TypeDirect peer
Description

Dante Labs is a direct-to-consumer whole genome sequencing provider offering 30x WGS and whole exome sequencing to consumers internationally. It is a direct competitor to Gencove Consumer in the WGS-based DTC testing category, with broader international availability.

TypeDirect peer
Description

Nebula Genomics offers direct-to-consumer whole genome sequencing with an emphasis on data privacy and ownership. It uses 30x whole genome sequencing rather than Gencove's low-pass approach, but competes for the same privacy-conscious, data-owning consumer seeking comprehensive genomic data.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gencove

Genomic Sequencing & Analyticsgencove.com

Gencove is a New York-based genomics technology company offering low-pass whole genome sequencing with proprietary imputation to pharmaceutical, academic, agricultural, and consumer customers via an enterprise platform and a $69 DTC test kit.

What Gencove does

Gencove is a New York-based genomics technology company founded in 2015 that commercializes low-pass whole genome sequencing (lpWGS) — a method that reads the entire genome at approximately 0.5x coverage and uses a proprietary imputation pipeline, calibrated against large reference panels and tuned for accuracy across diverse ancestries, to infer millions of additional variants at >99% concordance with microarray genotyping for common variants. The company operates a dual-track business: a direct-to-consumer product (Gencove Consumer, launched March 2026, $69 per kit) delivering PRS-based health risk reports across nine traits, ancestry analysis, and raw data download; and an enterprise platform (Gencove Enterprise / Base / Explorer) serving pharmaceutical companies, biobanks, academic institutions, and agricultural genomics customers with population-scale sequencing workflows, a JupyterLab-based analysis cloud, a Python CLI/SDK, and a REST API with multi-region deployment.

The enterprise platform generates revenue through subscription/recurring platform services and project-based sequencing contracts with named customers including GSK, Boehringer Ingelheim, Stanford University, the University of Oxford, the USDA, Syngenta, Neogen, BGI, Element Biosciences, Ultima Genomics, Gene by Gene, and the Weizmann Institute. The consumer channel operates as a one-time e-commerce transaction priced at $69 per kit, with US-only shipping as of the disclosure date and international expansion publicly signaled. The company has raised approximately $16.15M across five funding rounds through 2021 (latest: $10M Series A led by Lewis & Clark AgriFood), holds 11–50 employees per the disclosed band, and is led by CEO Joe Pickrell and CTO/Co-founder Tomaz Berisa. Technical differentiators include imputation optimized for diverse ancestries, raw data ownership for customers (enabling reanalysis as science evolves), CLIA-certified laboratory processing, and EU-U.S./UK/Swiss Data Privacy Framework certifications supporting international data handling.

Gencove firmographics

Firmographics
Name
Gencove
Legal name
Gencove, Inc.
Website
https://gencove.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Gencove is a New York-based genomics technology company offering low-pass whole genome sequencing with proprietary imputation to pharmaceutical, academic, agricultural, and consumer customers via an enterprise platform and a $69 DTC test kit.
Ownership category
akta.pro rank

Gencove industry classification

Industry
Product category
Genomic Sequencing & Analytics
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYAFAEAJAC
Genomic Testing & Genetic Evaluation Services
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAANAL
Population Genomics & Preventive Precision Health Programs

Keywords

  • Low-pass whole genome sequencing
  • Polygenic risk scoring
  • Consumer DNA testing
  • Genomic imputation platform
  • Enterprise genomics analytics

Where Gencove is headquartered

Location

Headquarters

HQ city
Long Island City
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Gencove business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Consumer DNA Testing Kits: Direct-to-consumer sales of at-home DNA collection kits at $69 per kit. Includes buccal swab collection, low-pass whole genome sequencing, polygenic risk score reports across 7+ health traits, ancestry analysis, and raw data download.
  2. Enterprise Genomic Platform: B2B platform services for research institutions, biobanks, and pharmaceutical companies including assay development, sequencing, and data analytics & management solutions for population-scale genomics research.
  3. Technology Partnership - Twist Bioscience: Collaboration with Twist Bioscience for the FlexPrep Ultra-High Throughput Library Preparation Kit for agrigenomics and population genomics applications.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-go$69 consumer DNA test kit

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Gencove product offering

Product offering

Core offering

Gencove sells low-pass whole genome sequencing (lpWGS) and imputation-based genomic analysis through two distinct channels: a direct-to-consumer $69 at-home DNA testing kit with Polygenic Risk Score reports across 8+ health traits and ancestry analysis, and an enterprise cloud platform (Gencove Base + Explorer) providing population-scale genomic sequencing, imputation, project/sample management, and analytical shortcuts for research institutions, biobanks, pharmaceutical companies, and agrigenomics customers. Both channels share the same proprietary lpWGS and imputation technology stack.

Product overview

Gencove operates as a genomics technology company offering a dual-track product portfolio. For consumers (Gencove Consumer), it provides at-home DNA testing using low-pass whole genome sequencing (lpWGS), delivering PRS-based health risk reports, ancestry analysis, and raw genomic data downloads for $69. For research and enterprise customers (Gencove Enterprise/Base), it provides a cloud-based sequencing analytics platform comprising Gencove Base (project/sample management via web dashboard, REST API, and CLI), Gencove Explorer (JupyterLab-based analysis cloud with shortcut library for VCF management, relatedness, and IGV), and the Gencove CLI (Python SDK). Both tracks share the same core lpWGS technology and imputation pipeline, with the consumer product packaging enterprise-grade genomic infrastructure into an accessible consumer offering.

Differentiator

Problem solved

Functional benefit

Brands

  • Gencove Enterprise Platform: Low-pass sequencing and imputation workflows for research institutions, biobanks, and pharmaceutical companies
  • Gencove Explorer
  • Gencove Base
  • Gencove Consumer

Products and services

  • Gencove Consumer DNA Test Kit
  • Gencove Enterprise Platform

Quantifiable outcome

  • >99% concordance with microarray genotyping for common variants (minor allele frequency >5%)

Companies that use Gencove

Customer profile

Named customers13 records

Segments4 records

Ideal customer profiles4 records

Gencove technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability2 records

Feature5 records

Gencove partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Twist BiosciencecoreTechnology or Integration · 30 October 2024Twist Bioscience launched the FlexPrep Ultra-High Throughput Library Preparation Kit designed for high-volume applications in agrigenomics and population genomics, collaborating with Gencove to enhance genomic analysis solutions. The kit offers significant cost and time savings by automating normalization and multiplexing processes, allowing up to 1,152 samples per run. The collaboration aims to accelerate adoption of next-generation sequencing (NGS) in large-scale genomic research.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Gencove competitors and assessment

Company assessment

Broad incumbents

  • Element Biosciences: Element Biosciences is a sequencing instrument manufacturer whose AVITI system is positioned as a lower-cost alternative to Illumina. It is listed as a Gencove trusted partner and represents adjacent sequencing infrastructure that competes with and complements Gencove's platform.
  • Ultima Genomics: Ultima Genomics is a sequencing instrument company developing high-throughput, low-cost NGS platforms. Gencove is listed as a trusted partner with Ultima integration (October 2025), making Ultima both an infrastructure partner and adjacent player in low-cost sequencing.
  • BGI: BGI is a global genomics organization with sequencing services, instrument manufacturing (MGI), and large-scale population genomics programs. It is a listed Gencove partner and broader incumbent in genomics services with significantly greater scale and geographic reach.

Direct peers

  • 23andMe: 23andMe is the largest direct-to-consumer genetic testing company, offering saliva-based DNA tests for ancestry and health traits. It is the most direct competitor to Gencove's $69 consumer kit, though 23andMe uses microarray genotyping rather than low-pass whole genome sequencing.
  • Ancestry (AncestryDNA): AncestryDNA is a major consumer genetic testing service focused primarily on ancestry and family history, with microarray-based genotyping. It competes directly with Gencove Consumer in the DTC market and has a substantially larger customer base and brand recognition.
  • Dante Labs: Dante Labs is a direct-to-consumer whole genome sequencing provider offering 30x WGS and whole exome sequencing to consumers internationally. It is a direct competitor to Gencove Consumer in the WGS-based DTC testing category, with broader international availability.
  • Nebula Genomics: Nebula Genomics offers direct-to-consumer whole genome sequencing with an emphasis on data privacy and ownership. It uses 30x whole genome sequencing rather than Gencove's low-pass approach, but competes for the same privacy-conscious, data-owning consumer seeking comprehensive genomic data.

Others

  • Twist Bioscience: Twist Bioscience is a synthetic biology and DNA synthesis company that partnered with Gencove on the FlexPrep Ultra-High Throughput Library Preparation Kit (October 2024). It is a key ecosystem partner enabling Gencove's agrigenomics throughput rather than a direct competitor.

Emerging players

  • Helix: Helix operates a sequencing-as-a-service platform serving health systems, population health programs, and consumer applications. It competes with Gencove Enterprise in population-scale genomic analysis and offers its own consumer-facing products through partners.
  • Color Health: Color Health provides genetic testing with a focus on clinical-grade health screening, population health programs, and enterprise health benefits. It overlaps with Gencove in genetic testing and population genomics but emphasizes clinical utility rather than raw data ownership or sequencing methodology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Gencove social profiles

Digital presence

Gencove compliance and trust

Trust signal

Compliance4 records

Gencove financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gencove leadership team

Management profile

Number of profiles

Profiles3 records

Gencove funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gencove M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gencove

What does Gencove do?

Gencove sells low-pass whole genome sequencing (lpWGS) and imputation-based genomic analysis through two distinct channels: a direct-to-consumer $69 at-home DNA testing kit with Polygenic Risk Score reports across 8+ health traits and ancestry analysis, and an enterprise cloud platform (Gencove Base + Explorer) providing population-scale genomic sequencing, imputation, project/sample management, and analytical shortcuts for research institutions, biobanks, pharmaceutical companies, and agrigenomics customers. Both channels share the same proprietary lpWGS and imputation technology stack.

Is Gencove a public or private company?

Gencove is a private company. It is classified as venture growth investor backed and is currently operating.

When was Gencove founded?

Gencove was founded in 2016. It employs 11 to 50 people.

Where is Gencove based?

Gencove is headquartered in Long Island City, United States, in the North America region.

How does Gencove make money?

Three revenue lines are on record. Consumer DNA Testing Kits are the primary driver. The others are enterprise Genomic Platform and technology Partnership - Twist Bioscience.

Who are Gencove's main competitors?

Broad incumbents on record are Element Biosciences, Ultima Genomics and BGI. Direct peers are 23andMe, Ancestry (AncestryDNA), Dante Labs and Nebula Genomics. Twist Bioscience is listed as an others. Emerging players are Helix and Color Health.

Does Gencove have an API?

Yes. REST API for managing genomic projects, samples, file uploads/downloads, analysis pipelines, and consumer reports. Authentication via API key (Authorization: Api-Key header) or email/password. Multi-environment support (e.g., EU host at api.eu1.gencove.com). The Gencove CLI (Python SDK) exposes these APIs via commands such as gencove upload, gencove explorer, and gencove explorer instances. OAuth support for consumer-facing sign-in (Google, Apple). Variant-level API access announced May 2026 for consumer genetics. MCP (Model Context Protocol) server/integration available for consumer genetics (announced April 2026). CLI is compatible with Python 3.8 and above; source mirrored on GitHub. Developer documentation is at api.gencove.com/api/v2/docs.

What industry is Gencove in?

Gencove's product category is Genomic Sequencing & Analytics. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePrecisionLife Selects Gencove as US Partner to Launch and Deliver DNA Wellness ReportsPrecisionLife selected Gencove as its US partner to launch DNA wellness reports, combining Gencove's low-pass whole genome sequencing with PrecisionLife's AI analysis. The first product, the Post COVID DNA Wellness Report, compares genomes to long COVID research patterns for educational purposes only. Further reports are planned over the next 12 months.BioSpaceTwist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population GenomicsTwist Bioscience announced the launch of its FlexPrep™ Ultra-High Throughput Library Preparation Kit, designed to streamline next-generation sequencing workflows for agrigenomics and population genomics. The kit utilizes proprietary Normalization by Ligation™ technology to enable high-throughput processing of up to 1,152 samples per run while significantly reducing consumable costs and labor. Twist is also collaborating with Gencove to provide an integrated end-to-end genomic analysis solution for customers adopting this new workflow.Stock TitanTwist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population GenomicsTwist Bioscience launched the FlexPrep UHT Library Preparation Kit, using Normalization by Ligation technology to process up to 1,152 samples per 96-well plate. The kit reduces consumables by 12-fold and pairs with Gencove's analysis software for end-to-end genotyping.Business Wire BlogTwist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population GenomicsTwist Bioscience launched the FlexPrep UHT Library Preparation Kit, using its Normalization by Ligation technology to enable up to 1,152 samples per 96-well plate. The kit reduces consumables by 12-fold and pairs with Gencove for genomic analysis.YahooTwist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population GenomicsTwist Bioscience launched the FlexPrep UHT library preparation kit, using its Normalization by Ligation technology to process up to 1,152 samples per 96-well plate. The kit reduces consumables by 12-fold and pairs with Gencove's analysis software for end-to-end genotyping.Business Wire BlogTwist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population GenomicsTwist Bioscience launched the FlexPrep UHT Library Preparation Kit, using Normalization by Ligation technology to process up to 1,152 samples per 96-well plate. The kit reduces consumables by 12-fold and pairs with Gencove's analysis software for agrigenomics and population genomics.GlobeNewswireGencove and Prime Pursuits Announce Partnership to Bring Genomic Management Solutions to Beef Supply ChainsGencove and Prime Pursuits announced a partnership to integrate genomic management across the beef supply chain, targeting Walmart customers in 565 Southeast stores. The initiative uses Prime Pursuits' Prime Intelligence database to build customized breeding values and sustainable feedlot tools. The collaboration aims to enhance transparency and return data to ranch partners.YahooGencove and Prime Pursuits Announce Partnership to Bring Genomic Management Solutions to Beef Supply ChainsGencove and Prime Pursuits announced a partnership to integrate genomic management across the beef supply chain, targeting Walmart customers in 565 Southeast stores. The initiative uses Prime Pursuits' Prime Intelligence database to build customized breeding values and return data to ranchers. The collaboration aims to enhance sustainability and efficiency in beef production.GlobeNewswireEurofins Genomics AgriGenomics Europe and Gencove announce collaboration to offer complete solution for low-pass whole genome sequencingEurofins Genomics AgriGenomics Europe and Gencove announced a partnership to offer a complete low-pass whole genome sequencing solution in Europe. The collaboration combines Gencove's analytics platform with Eurofins' sequencing capabilities to provide cost-effective genotyping for species without SNP arrays. The partnership aims to broaden access to affordable sequencing for researchers.GlobeNewswireGencove Appoints Alex Dickinson to its Board of DirectorsGencove appointed Alex Dickinson to its Board of Directors, bringing experience from Illumina and co-founder roles. He will join co-founders Joseph Pickrell and Tomaz Berisa, and other board members. The company's low-pass whole genome sequencing platform targets the $4B genotyping market.